Pyraclostrobin Exposure Triggers Renal Injury by Activating Wnt/β‐Catenin Signaling Pathway‐Mediated Renal Fibrosis in Mice
ABSTRACT Pyraclostrobin (PY) is a commonly applied strobilurin‐class fungicide that is frequently identified as a residue in food products, yet its nephrotoxic mechanisms remain unclear. Here, a 28‐day oral gavage mouse model (1/10 and 1/5 LD 50 ) and an HK‐2 cell model (1/10 and 1/5 IC 50 ) were established to investigate PY‐induced nephrotoxicity. Histopathological analysis revealed glomerular hypertrophy, mesangial expansion, inflammatory infiltration, capillary congestion, and tubular epithelial degeneration. Biochemical assays revealed that PY significantly elevated the levels of blood urea nitrogen (BUN), creatinine (CRE), kidney injury molecule‐1 (KIM‐1), and neutrophil gelatinase‐associated lipocalin (NGAL), indicating impaired renal function. Quantitative real‐time polymerase chain reaction (qRT‐PCR) analysis further demonstrated increased mRNA expression of tumor necrosis factor‐α (TNF‐α), interleukin‐6 (IL‐6), and interleukin‐1β (IL‐1β), accompanied by decreased interleukin‐10 (IL‐10) expression. Masson's staining and protein analyses confirmed enhanced extracellular matrix deposition and fibrosis, with increased expression of collagen I, transforming growth factor‐β1 (TGF‐β1), α‐smooth muscle actin (α‐SMA), and connective tissue growth factor (CTGF). Moreover, PY markedly activated the Wnt/β‐catenin signaling pathway, as evidenced by elevated levels of phosphorylated β‐catenin (P‐β‐catenin), β‐catenin, c‐Myc, phosphorylated glycogen synthase kinase‐3β (P‐GSK3β), and Cyclin D1. Inhibition with ICG‐001 significantly attenuated PY‐induced fibrosis, confirming Wnt/β‐catenin‐dependent effects. These findings provide mechanistic insight into PY‐induced renal injury and fibrosis.
Authors
- Tong Zhou (ORCID: https://orcid.org/0009-0003-7708-0942)
- Yunlong Sang
- Yuanyuan Li (ORCID: https://orcid.org/0000-0002-7612-8989)
- Dong Su
- Binwu Zhuang
- Jingjing Chen
- Hao Liu (ORCID: https://orcid.org/0009-0006-8611-3533)
- Bin Liu
Institutions
- Kanion Pharmaceutical (China) (CN)
- The First People’s Hospital of Lianyungang (CN)
Publication Details
- Journal
- Journal of Applied Toxicology
- Published
- 2026-06-28
- DOI
- https://doi.org/10.1002/jat.70313
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00